Inhalopédia | Inhalers

Class
- Long-acting muscarinic antagonist (LAMA)
Active ingredient
- Aclidinium bromide
Device
- Genuair®
Inhalers techniques and maintenance
Age
- 18 +
Typical use
- Asthma (off-label)
  in addition to a high dose ICS + LABA when uncontrolled
Asthma management principles
- COPD
  initial treatment or in addition to a LABA when uncontrolled
COPD management principles
Marketed strength
- 400 mcg
Number of doses
- 60 doses
Dose indicator
- Yes | Indicator
Usual adult dosage
- 1 inh BID
Usual pediatric dosage
- -
Required inspiratory flow
- > 40 - 45 L/min
  Medium internal resistance (R3)
Inspiratory flows
Public coverage
- AB – MN – NIHB – ON – QC | Open/Regular Benefit
  BC – NB –NL – NS – PEI – SK – YT | Restricted Benefit with criteria
Provincial coverage criteria
Advantages
- Less anticholinergic side effects
- Easy handling
- Impossible to take empty (locking mechanism)
Disadvantages
- Taste that can be unpleasant
- BID dosing
- May fail to actuate despite good inspiratory flow
Side effects

Product monograph

Download

Tudorza®